Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals
4485 Congresses
10100+ Unique Records

Immuno-Oncology Technology


Title Abbreviation
IOTECH
Electronic ISSN
2590-0188
Readership
Biomedical Engineers/Technologists, Biomedical Researchers, Cell Biologists, Clinicians, Cytologists, Hematologists, Immunologists, Molecular Biologists, Oncologists, Researchers
Scope
Immuno-Oncology Technology (IOTECH) is a new, peer-reviewed open access journal from ESMO publishing high quality original research articles, reviews and editorials focusing on novel immuno-oncology topics and developments, both clinically and preclinically. Led by an international team of expert Editors and Editorial Board members IOTECH will focus on: • Adoptive cell therapy, including tumor infiltrating lymphocytes and gene modified cells; • Cancer vaccine development, including neoantigen vaccines; • Intratumoral immunotherapy; • New macromolecules, such as bispecific or trispecific antibodies, nanobodies, designed ankyrin repeat proteins and immunocytokines; • Biomarker research aimed towards developing precision immunotherapy, including immuno-oncology diagnostics both in peripheral blood (ctDNA, chemokines profiles etc.) and in the tumor, including tumor mutational burden, single cell analysis (genomics, transcriptomics, proteomics), metabolomics, molecular imaging and microbiome; • First in human trials, phase I and newly designed phase II trials.
Sponsoring Association(s)
European Society for Medical Oncology (ESMO)
Publisher Name
Elsevier Inc - NY
To see more details about Immuno-Oncology Technology, Subscribe Now!
Electronic Circulation Acceptance to Online Publication Rejection Rate Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library